India to Myanmar: Metoprolol Export Trade Route

The India to Myanmar Metoprolol corridor is one of India's established pharmaceutical export routes, with 80 shipments documented worth a combined $2.8M USD. The route is dominated by EMCURE PHARMACEUTICALS LIMITED, which alone accounts for roughly 71% of all export value, reflecting the consolidated nature of India's metoprolol manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $34.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 13.0%, placing it at rank #10 among India's top metoprolol export destinations globally.

On the import side, key buyers of Indian metoprolol in Myanmar include KHETAN COMPANY LIMITED, J.D.S CO.LTD, J.D.S CO.LIMITED and 10 others. KHETAN COMPANY LIMITED is the single largest importer with 38 shipments valued at $2.0M USD.

India's metoprolol exports to Myanmar are driven primarily by a handful of large-scale manufacturers. EMCURE PHARMACEUTICALS LIMITED with 38 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EMCURE PHARMACEUTICALS LIMITED, IPCA LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 97% of total trade value on this route. The average shipment value of $34.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceuticals products finished product metpure xl 12 5 mg tablet 10x10 s metoprolol succinate extended rele and pharmaceuticals products finished product metpure xl 25 mg tablet 10x10 s metoprolol succinate extended relea, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, KHETAN COMPANY LIMITED is the largest importer with 38 shipments worth $2.0M USD — representing 71% of all metoprolol imports from India on this route. A total of 13 buyers are active on this corridor.